108 related articles for article (PubMed ID: 3069486)
21. [Clinical and hemodynamic evaluation of 6-week treatment of pulmonary hypertension in chronic obstructive lung diseases (COLD) with low dose of prazosin].
Lewczuk J; Spikowski J; Sobkowicz-Woźniak B; Porada A; Wrabec K; Trzesicka M; Piszko P; Palka PS; Szczygielski J
Kardiol Pol; 1990; 33(6):358-64. PubMed ID: 2084301
[TBL] [Abstract][Full Text] [Related]
22. [Hypoxic pulmonary hypertension: nifedipine therapy].
Agostoni P; Doria E; Galli C; Tamborini G; Fiorentini C; Guazzi M
Cardiologia; 1988 Oct; 33(10):961-9. PubMed ID: 3233606
[No Abstract] [Full Text] [Related]
23. Hemodynamic and oxygen delivery responses to nifedipine in pulmonary hypertension secondary to chronic obstructive lung disease.
Saadjian A; Philip-Joet F; Arnaud A
Cardiology; 1987; 74(3):196-204. PubMed ID: 3594508
[TBL] [Abstract][Full Text] [Related]
24. [Effects of diprophylline on pulmonary hypertension in patients with chronic pulmonary disease].
Kang J
Zhonghua Jie He He Hu Xi Za Zhi; 1992 Jun; 15(3):153-4, 190. PubMed ID: 1473187
[TBL] [Abstract][Full Text] [Related]
25. Hemodynamic effects of nifedipine in pulmonary hypertension.
Klugmann S; Salvi A; Fioretti P; Camerini F
G Ital Cardiol; 1982; 12(7):505-8. PubMed ID: 7169146
[TBL] [Abstract][Full Text] [Related]
26. Disappearance of molsidomine effects on pulmonary circulation of patients with chronic obstructive pulmonary disease after a three week treatment.
Lampert E; Tuo N; Frans A; Lonsdorfer J
Pathol Biol (Paris); 1991 Jan; 39(1):29-33. PubMed ID: 2011406
[TBL] [Abstract][Full Text] [Related]
27. [Hemodynamic studies of nifedipine (Adalat) in pulmonary hypertension in childhood].
Wimmer M; Schlemmer M; Ebner F
Wien Klin Wochenschr; 1986 Nov; 98(21):740-3. PubMed ID: 3101292
[TBL] [Abstract][Full Text] [Related]
28. [Short-term effects of Angelica sinensis and nifedipine on chronic obstructive pulmonary disease in patients with pulmonary hypertension].
Xu JY; Li BX; Cheng SY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1992 Dec; 12(12):716-8, 707. PubMed ID: 1304838
[TBL] [Abstract][Full Text] [Related]
29. [Effect of large doses of nifedipine on pulmonary hypertension in patients with recurrent pulmonary thromboembolism].
Pałasiewicz G; Tomkowski W; Hajduk B; Fijałkowska A; Radomyski A; Filipecki S; Polowiec Z
Pneumonol Alergol Pol; 1994; 62(3-4):143-9. PubMed ID: 8061639
[TBL] [Abstract][Full Text] [Related]
30. [Hemodynamic effects of the administration of nifedipine over an 18-month period in pulmonary arterial hypertension in chronic obstructive bronchopneumopathies].
Vestri R; Joet FP; Saadjian A; Arnaud A
Presse Med; 1988 Feb; 17(5):213-4. PubMed ID: 2965386
[No Abstract] [Full Text] [Related]
31. A one year double blind follow-up of blood gas tensions and haemodynamics in almitrine bismesylate therapy.
Préfaut C; Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J
Eur Respir J; 1988 Jan; 1(1):41-50. PubMed ID: 2896600
[TBL] [Abstract][Full Text] [Related]
32. The effect of a new calcium antagonist, felodipine, on pulmonary hypertension and gas exchange in chronic obstructive lung disease.
Bratel T; Hedenstierna G; Nyquist O; Ripe E
Eur J Respir Dis; 1985 Oct; 67(4):244-53. PubMed ID: 4076363
[TBL] [Abstract][Full Text] [Related]
33. Acute effects of nifedipine administration in pulmonary haemodynamics and oxygen delivery during exercise in patients with chronic obstructive pulmonary disease: implication of the angiotensin-converting enzyme gene polymorphisms.
Kanazawa H; Tateishi Y; Yoshikawa J
Clin Physiol Funct Imaging; 2004 Jul; 24(4):224-8. PubMed ID: 15233837
[TBL] [Abstract][Full Text] [Related]
34. [Effects of tetrandrine on pulmonary hypertension in patients with chronic obstructive pulmonary disease].
Kang J
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):93-4, 124. PubMed ID: 8221961
[TBL] [Abstract][Full Text] [Related]
35. [Long-term clinical study of nifedipine in the treatment of pulmonary arterial hypertension in chronic obstructive bronchopneumopathies].
Vestri R; Philip-Joft F; Saadjian A; Lagier F; Arnaud A
Presse Med; 1987 Sep; 16(29):1437. PubMed ID: 2958810
[No Abstract] [Full Text] [Related]
36. [The long-term effect of nifedipine (control release tablets) in patients with chronic obstructive pulmonary disease and cor pulmonale].
Cheng X; Yao Z; Li Q
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Apr; 20(2):84-7. PubMed ID: 10072830
[TBL] [Abstract][Full Text] [Related]
37. Nifedipine inhibits the effects of almitrine in patients suffering from pulmonary artery hypertension secondary to chronic obstructive pulmonary disease.
Saadjian A; Philip-Joët F; Barret A; Levy S; Arnaud A
J Cardiovasc Pharmacol; 1993 May; 21(5):797-803. PubMed ID: 7685452
[TBL] [Abstract][Full Text] [Related]
38. [Effect of the calcium antagonist nifedipine on central and peripheral hemodynamics in patients with primary pulmonary hypertension].
Khosseĭn A; Mareev VIu; Ageev FT; Sazonova LN; Lobova NM
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):78-81. PubMed ID: 3401345
[TBL] [Abstract][Full Text] [Related]
39. Differential therapy with calcium antagonists in pulmonary hypertension secondary to COPD. Hemodynamic effects of nifedipine, diltiazem, and verapamil.
Gassner A; Sommer G; Fridrich L; Magometschnigg D; Priol A
Chest; 1990 Oct; 98(4):829-34. PubMed ID: 2209138
[TBL] [Abstract][Full Text] [Related]
40. [Effects of nifedipine in patients with unstable chronic obstructive pulmonary disease].
Seoane M; Verdejo J; Sandoval J; Lupi E
Arch Inst Cardiol Mex; 1986; 56(2):109-16. PubMed ID: 2942120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
